ARCHETYPE Recommendation on the treatment of AMD (openEHR-EHR-EVALUATION.recommendation-amd_treatment.v0)

Name: Recommendation on the treatment of AMD
License: http://creativecommons.org/licenses/by-sa/3.0/

ARCHETYPE ID	openEHR-EHR-EVALUATION.recommendation-amd_treatment.v0
Concept	Recommendation on the treatment of AMD
Description	A suggestion, advice or proposal toward application of the appropriate therapy for patients diagnosed with age-related macular degeneration.
Use	Use to record a suggestion, advice or proposal about the treatment of age-related macular degeneration, valid at a specific time of healthcare. The statement is considered for the specific point-in-time it is registered, as the therapeutic guidelines may vary according to the context of the disease and the information evaluated in each clinical encounter. For example, the treatment can be modified over time depending on the progression of the disease.
Purpose	To record a suggestion, advice or proposal about the most suitable treatment at a specific time, for each patient with age-related macular degeneration.
References
Copyright	© openEHR Foundation
Authors	Author name: Aitor Eguzkitza Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra Email: aitor.eguzkiza@unavarra.es Date originally authored: 2015-07-04
Other Details Language	Author name: Aitor Eguzkitza Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra Email: aitor.eguzkiza@unavarra.es Date originally authored: 2015-07-04
OtherDetails Language Independent	{licence=This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/3.0/., custodian_organisation=openEHR Foundation, current_contact=Aitor Eguzkitza, Universidad Pública de Navarra - Complejo Hospitalario de Navarra, original_namespace=org.openehr, original_publisher=openEHR Foundation, custodian_namespace=org.openehr, MD5-CAM-1.0.1=90F3DB6FB27CA260C42AE260C3122C98, build_uid=9badbeec-d858-46a3-876b-a77f71e4bfbb, revision=0.0.1-alpha}
Keywords	advice, proposal, suggestion, treatment, age-related macular degeneration, amd
Lifecycle	in_development
UID	eef4b601-8d7d-4a3b-a7b6-d199eee2fafd
Language used	en
Citeable Identifier	1013.1.1823
Revision Number	0.0.1-alpha
All	Archetype [runtimeNameConstraintForConceptName=null, archetypeConceptBinding=null, archetypeConceptDescription=A suggestion, advice or proposal toward application of the appropriate therapy for patients diagnosed with age-related macular degeneration., archetypeConceptComment=null, otherContributors=Koray Atalag, University of Auckland, New Zealand Silje Ljosland Bakke, Bergen Hospital Trust, Norway (openEHR Editor) Lars Bitsch-Larsen, Haukeland University hospital, Norway Einar Fosse, National Centre for Integrated Care and Telemedicine, Norway Sam Heard, Ocean Informatics, Australia Lars Karlsen, DIPS ASA, Norway Shinji Kobayashi, Kyoto University, Japan Heather Leslie, Ocean Informatics, Australia (openEHR Editor) Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor) Andrej Orel, Marand d.o.o., Slovenia José Andonegui, Hospital de Navarra, jose.andonegui.navarro@cfnavarra.es Luis Serrano, Universidad Pública de Navarra (UPNA), lserrano@unavarra.es Jesús D. Trigo, Universidad Pública de Navarra (UPNA), jesusdaniel.trigo@unavarra.es, originalLanguage=en, translators= Spanish (Spain): ? , subjectOfData=unconstrained, archetypeTranslationTree=null, topLevelToAshis={source=[], identities=[], contacts=[], ism_transition=[], provider=[], protocol=[], description=[], events=[], details=[], context=[], target=[], capabilities=[], items=[], other_participations=[], content=[], state=[], activities=[], data=[ResourceSimplifiedHierarchyItem [path=/data[at0001]/items[at0002.1], code=at0002.1, itemType=ELEMENT, level=2, text=Therapeutic recommendation, description=Narrative description of the most effective treatment based on a previous assessment of AMD., comment=null, uncommonOntologyItems=null, occurencesFormal=0..1, occurencesText=Optional, cardinalityFormal=null, cardinalityText=null, subCardinalityFormal=null, subCardinalityText=null, dataType=DV_CODED_TEXT, bindings=[SNOMED-CT::118910000 \| Procedure on posterior segment of eye], values= at0.4::Do not treat [Observation of the condition is recommended when no treatment is indicated or the afection is not tratable.] [SNOMED-CT::183964008 \| Treatment not indicated] at0.5::Intravitreal anti-VEGF injection [Inhibition of neovascularization may delay or even halt progression of exudative form of AMD.] at0.12::High dose Antioxidant Vitamin and Mineral Supplements [Daily intake of certain antioxidants and minerals can help slow the progression of age-related macular degeneration (AMD).] at0.11::Photodynamic Therapy (PDT) [A light-sensitive medicine is injected into the bloodstream, and blocks selectively abnormal blood vessels under the macula in response to laser light. PDT is applicable to stop further formation of wet AMD, but it cannot reverse damage.] [SNOMED-CT::257891001 \| Photodynamic therapy] at0.14::Thermal Laser Photocoagulation Surgery [By treating the abnormal blood vessels that have formed on the retina, laser surgery can delay advancement of the disease.] [SNOMED-CT::399867007 \| Laser photocoagulation to retina] Assumed value: Do not treat, extendedValues=null], ResourceSimplifiedHierarchyItem [path=/data[at0001]/items[at0003.1], code=at0003.1, itemType=ELEMENT, level=2, text=Rationale, description=Justification for the recommendation., comment=null, uncommonOntologyItems=null, occurencesFormal=0.., occurencesText=Optional, repeating, cardinalityFormal=null, cardinalityText=null, subCardinalityFormal=null, subCardinalityText=null, dataType=DV_CODED_TEXT, bindings=null, values= at0.15::Visual acuity decrease with macular fluid [Loss of at least one line of visual acuity, in comparison to the previous revision, associated with the presence of macular fluid indicative of activity on AMD.] at0.16::Macular fluid [Persistence of intraretinal or subretinal macular fluid indicative of AMD activity.] [SNOMED-CT::421843005 \| Subretinal fluid] at0.17::New macular haemorrhage [Emerging new macular haemorrhage detected.] [SNOMED-CT::247161000 \| Macular subretinal haemorrhage] , extendedValues=null]], relationships=[], credentials=[]}, topLevelItems={data=ResourceSimplifiedHierarchyItem [path=ROOT_/data[at0001], code=at0001, itemType=ITEM_TREE, level=0, text=null, description=null, comment=null, uncommonOntologyItems=null, occurencesFormal=1..1, occurencesText=Mandatory, cardinalityFormal=0..1, cardinalityText=optional, subCardinalityFormal=0.., subCardinalityText=Minimum of 0 items (Cardinality: 0.., unordered), dataType=ITEM_TREE, bindings=null, values=null, extendedValues=null]}, addHierarchyItemsTo=data, currentHierarchyItemsForAdding=[ResourceSimplifiedHierarchyItem [path=/data[at0001]/items[at0002.1], code=at0002.1, itemType=ELEMENT, level=2, text=Therapeutic recommendation, description=Narrative description of the most effective treatment based on a previous assessment of AMD., comment=null, uncommonOntologyItems=null, occurencesFormal=0..1, occurencesText=Optional, cardinalityFormal=null, cardinalityText=null, subCardinalityFormal=null, subCardinalityText=null, dataType=DV_CODED_TEXT, bindings=[SNOMED-CT::118910000 \| Procedure on posterior segment of eye], values= at0.4::Do not treat [Observation of the condition is recommended when no treatment is indicated or the afection is not tratable.] [SNOMED-CT::183964008 \| Treatment not indicated] at0.5::Intravitreal anti-VEGF injection [Inhibition of neovascularization may delay or even halt progression of exudative form of AMD.] at0.12::High dose Antioxidant Vitamin and Mineral Supplements [Daily intake of certain antioxidants and minerals can help slow the progression of age-related macular degeneration (AMD).] at0.11::Photodynamic Therapy (PDT) [A light-sensitive medicine is injected into the bloodstream, and blocks selectively abnormal blood vessels under the macula in response to laser light. PDT is applicable to stop further formation of wet AMD, but it cannot reverse damage.] [SNOMED-CT::257891001 \| Photodynamic therapy] at0.14::Thermal Laser Photocoagulation Surgery [By treating the abnormal blood vessels that have formed on the retina, laser surgery can delay advancement of the disease.] [SNOMED-CT::399867007 \| Laser photocoagulation to retina] Assumed value:* Do not treat, extendedValues=null], ResourceSimplifiedHierarchyItem [path=/data[at0001]/items[at0003.1], code=at0003.1, itemType=ELEMENT, level=2, text=Rationale, description=Justification for the recommendation., comment=null, uncommonOntologyItems=null, occurencesFormal=0.., occurencesText=Optional, repeating, cardinalityFormal=null, cardinalityText=null, subCardinalityFormal=null, subCardinalityText=null, dataType=DV_CODED_TEXT, bindings=null, values= at0.15::Visual acuity decrease with macular fluid [Loss of at least one line of visual acuity, in comparison to the previous revision, associated with the presence of macular fluid indicative of activity on AMD.] at0.16::Macular fluid [Persistence of intraretinal or subretinal macular fluid indicative of AMD activity.] [SNOMED-CT::421843005 \| Subretinal fluid] at0.17::New macular haemorrhage [Emerging new macular haemorrhage detected.] [SNOMED-CT*::247161000 \| Macular subretinal haemorrhage] , extendedValues=null]], minIndents={}, termBindingRetrievalErrorMessage=null]